Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Endocrine 2

Conditions

Neuroendocrine Tumors 1Intestinal Neuroendocrine Tumor 1

Interventions

Standard of Care 172Blood Specimen Collection 133Exercise 121Educational Status 113Methods 107Surveys and Questionnaires 104Practice Guidelines as Topic 104Interviews as Topic 103Early Intervention, Educational 92Magnetic Resonance Spectroscopy 79Specimen Handling 74Radiosurgery 67Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 35Drug Therapy 32Therapeutics 31Resistance Training 31Surgical Procedures, Operative 30Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Exercise Test 24Nutrition Assessment 23Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Data Collection × 1 year × Clear all
NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting
150 enrolled
EndocrineNET

Intestinal Neuroendocrine Tumor

NCT05017662 2025-09-04

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Ariceum Therapeutics GmbH

Phase NA Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡